New shot aims to stop stroke damage in its tracks
NCT ID NCT07301372
Summary
This study is testing whether adding an injectable cholesterol-lowering drug (evolocumab) to standard stroke treatment can help prevent patients from getting worse in the first week after a stroke. It involves 132 adults who have just had an ischemic stroke caused by clogged arteries and received clot-busting medication. Researchers will compare those who get the extra drug injection to those who receive only standard medications, looking at whether it reduces early neurological decline and improves 90-day recovery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Neurology
RECRUITINGXuzhou, Jiangsu, China
Contact
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.